Table 2.
Demographic characteristics and baseline data of the total sample and of both cohorts (control and review cohorts)
| Total (N = 218) | Control cohort (N = 125) | Review cohort (N = 93) | P value | |
|---|---|---|---|---|
| Female, n (%) | 98 (45%) | 58 (46%) | 40 (43%) | 0.62 |
| Age mean, ± SD (range), years | 83 ± 6 (70–98) | 82 ± 6 (70–97) | 83 ± 8 (70–98) | 0.67 |
| Living at home before admission, n (%) | 179 (82%) | 104 (83%) | 75 (81%) | 0.72 |
| CCI, mean ± SD (range) | 7 ± 2 (3–16) | 7 ± 2 (3–16) | 7 ± 2 (3–14) | 0.82 |
| Number of medications, mean ± SD (range) | 9 ± 4 (0–24) | 8 ± 4 (1–19) | 10 ± 5 (0–24) | < 0.001 |
CCI Charlson Comorbidity Index, SD standard deviation